USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

Covid-19

Radiopharmaceutical Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

report img

Radiopharmaceutical Market By Type (Diagnostic, and Therapeutic) and By Application (Neurology, Oncology, Thyroid, Cardiology, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the radiopharmaceutical industry. The report analyzes and declares the historical and current trends analysis of the radiopharmaceutical industry and subsequently recommends the projected trends anticipated to be observed in the radiopharmaceutical market during the upcoming years.

The radiopharmaceutical market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire radiopharmaceutical market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Billion) and volume (K Units) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the radiopharmaceutical industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the radiopharmaceutical industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the radiopharmaceutical market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the radiopharmaceutical industry. The radiopharmaceutical market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the radiopharmaceutical sector. Key strategic developments in the radiopharmaceutical market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the radiopharmaceutical market are appropriately highlighted in the report.

The radiopharmaceutical market research report delivers an acute valuation and taxonomy of the radiopharmaceutical industry by practically splitting the market on the basis of different types, application and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the radiopharmaceutical industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the radiopharmaceutical industry is provided for the leading economies of the world.

Radiopharmaceutical is a formulation composed of radioactive substances such as radioisotopes, radionuclides, etc. Radiopharmaceuticals are used primarily for diagnostic and therapy purposes in clinical fields. The radiopharmaceutical has different shelf life depending on the parameters, including radiochemical stability, the radioisotope's physical half-life, and the content of long-lived radionuclide impurities in the preparation being considered.

The radiopharmaceutical market is segmented based on type, application and region. On the basis of type segmentation, the market is classified into diagnostic, and therapeutic. Based on application, the market is segregated into neurology, oncology, thyroid, cardiology, and others.

Some of the essential players operating in the radiopharmaceutical market, but not restricted to include Lantheus Medical Imaging, Inc., Cardinal Health Inc., GE Healthcare, Nordion, Inc., Eczacibasi-Monrol Nuclear Products, Bracco Imaging S.p.A, Nihon Medi-Physics Co., Ltd., and Advanced Accelerator Applications S.A, Curium, and Others.

logoThe taxonomy of the radiopharmaceutical industry by its scope and segmentation is as follows:

logoGlobal Radiopharmaceutical Market: By Type Segmentation Analysis

  • Diagnostic
    • SPECT
    • PET
  • Therapeutic
    • Brachytheraphy
    • Alpha Emitters
    • Beta Emitters

logoGlobal Radiopharmaceutical Market: By Application Segmentation Analysis

  • Neurology
  • Oncology
  • Thyroid
  • Cardiology
  • Others

logoGlobal Radiopharmaceutical Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
key report pointers

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Radiopharmaceutical market – Type Analysis
    1. 2.1. Global Radiopharmaceutical Market–TypeOverview
    2. 2.2. Global RadiopharmaceuticalMarketShare, by Type, 2019 & 2026 (USD Billion)
    3. 2.3. Global Radiopharmaceutical Market share, by Type, 2019 & 2026 (K Units)
    4. 2.4. Diagnostic
      1. 2.4.1. Global DiagnosticRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      2. 2.4.2. Global DiagnosticRadiopharmaceutical Market, 2016-2026 (K Units)
    5. 2.5. Therapeutic
      1. 2.5.1. Global TherapeuticRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      2. 2.5.2. Global TherapeuticRadiopharmaceutical Market, 2016-2026 (K Units)
  3. CHAPTER 3. Radiopharmaceutical market – Application Analysis
    1. 3.1. Global Radiopharmaceutical Market–ApplicationOverview
    2. 3.2. Global RadiopharmaceuticalMarketShare, by Application, 2019 & 2026 (USD Billion)
    3. 3.3. Global Radiopharmaceutical Market share, by Application, 2019 & 2026 (K Units)
    4. 3.4. Neurology
      1. 3.4.1. Global NeurologyRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      2. 3.4.2. Global NeurologyRadiopharmaceutical Market, 2016-2026 (K Units)
    5. 3.5. Oncology
      1. 3.5.1. Global OncologyRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      2. 3.5.2. Global OncologyRadiopharmaceutical Market, 2016-2026 (K Units)
    6. 3.6. Thyroid
      1. 3.6.1. Global ThyroidRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      2. 3.6.2. Global ThyroidRadiopharmaceutical Market, 2016-2026 (K Units)
    7. 3.7. Cardiology
      1. 3.7.1. Global CardiologyRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      2. 3.7.2. Global CardiologyRadiopharmaceutical Market, 2016-2026 (K Units)
    8. 3.8. Others
      1. 3.8.1. Global OthersRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      2. 3.8.2. Global OthersRadiopharmaceutical Market, 2016-2026 (K Units)
  4. CHAPTER 4. Radiopharmaceutical market – Regional Analysis
    1. 4.1. Global Radiopharmaceutical MarketRegionalOverview
    2. 4.2. Global RadiopharmaceuticalMarketShare, by Region, 2019 & 2026 (Value)
    3. 4.3. Global Radiopharmaceutical Market Share, by Region, 2019 & 2026 (Volume)
  5. CHAPTER 5. RadiopharmaceuticalProduction, Consumption, Export, Import by Regions
    1. 5.1. Global Radiopharmaceutical production and revenue, 2016-2026 (USD Billion) (K Units)
    2. 5.2. Global Import and Export Analysis, by Region
  6. CHAPTER 6. Radiopharmaceutical market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Competitor Market Share – Volume
    4. 6.4. Strategic Development
      1. 6.4.1. Acquisitions and Mergers
      2. 6.4.2. New Products
      3. 6.4.3. Research & Development Activities
  7. CHAPTER 7. Company Profiles
    1. 7.1. Lantheus Medical Imaging
      1. 7.1.1. Company Overview
      2. 7.1.2. Lantheus Medical Imaging Sales, Revenue, Price, and Gross Margin
      3. 7.1.3. Product portfolio
      4. 7.1.4. Recent initiatives
    2. 7.2. Inc.
      1. 7.2.1. Company Overview
      2. 7.2.2. Inc. Sales, Revenue, Price, and Gross Margin
      3. 7.2.3. Product portfolio
      4. 7.2.4. Recent initiatives
    3. 7.3. Cardinal Health Inc.
      1. 7.3.1. Company Overview
      2. 7.3.2. Cardinal Health Inc. Sales, Revenue, Price, and Gross Margin
      3. 7.3.3. Product portfolio
      4. 7.3.4. Recent initiatives
    4. 7.4. GE Healthcare
      1. 7.4.1. Company Overview
      2. 7.4.2. GE Healthcare Sales, Revenue, Price, and Gross Margin
      3. 7.4.3. Product portfolio
      4. 7.4.4. Recent initiatives
    5. 7.5. Nordion
      1. 7.5.1. Company Overview
      2. 7.5.2. Nordion Sales, Revenue, Price, and Gross Margin
      3. 7.5.3. Product portfolio
      4. 7.5.4. Recent initiatives
    6. 7.6. Inc.
      1. 7.6.1. Company Overview
      2. 7.6.2. Inc. Sales, Revenue, Price, and Gross Margin
      3. 7.6.3. Product portfolio
      4. 7.6.4. Recent initiatives
    7. 7.7. Eczacibasi-Monrol Nuclear Products
      1. 7.7.1. Company Overview
      2. 7.7.2. Eczacibasi-Monrol Nuclear Products Sales, Revenue, Price, and Gross Margin
      3. 7.7.3. Product portfolio
      4. 7.7.4. Recent initiatives
    8. 7.8. Bracco Imaging S.p.A
      1. 7.8.1. Company Overview
      2. 7.8.2. Bracco Imaging S.p.A Sales, Revenue, Price, and Gross Margin
      3. 7.8.3. Product portfolio
      4. 7.8.4. Recent initiatives
    9. 7.9. Nihon Medi-Physics Co.
      1. 7.9.1. Company Overview
      2. 7.9.2. Nihon Medi-Physics Co. Sales, Revenue, Price, and Gross Margin
      3. 7.9.3. Product portfolio
      4. 7.9.4. Recent initiatives
    10. 7.10. Ltd.
      1. 7.10.1. Company Overview
      2. 7.10.2. Ltd. Sales, Revenue, Price, and Gross Margin
      3. 7.10.3. Product portfolio
      4. 7.10.4. Recent initiatives
    11. 7.11. and Advanced Accelerator Applications S.A
      1. 7.11.1. Company Overview
      2. 7.11.2. and Advanced Accelerator Applications S.A Sales, Revenue, Price, and Gross Margin
      3. 7.11.3. Product portfolio
      4. 7.11.4. Recent initiatives
    12. 7.12. Curium
      1. 7.12.1. Company Overview
      2. 7.12.2. Curium Sales, Revenue, Price, and Gross Margin
      3. 7.12.3. Product portfolio
      4. 7.12.4. Recent initiatives
  8. CHAPTER 8. Radiopharmaceutical — Industry Analysis
    1. 8.1. Introduction and Taxonomy
    2. 8.2. Radiopharmaceutical Market – Key Trends
      1. 8.2.1. Market Drivers
      2. 8.2.2. Market Restraints
      3. 8.2.3. Market Opportunities
    3. 8.3. Value Chain Analysis
    4. 8.4. Key Mandates and Regulations
    5. 8.5. Technology Roadmap and Timeline
    6. 8.6. Radiopharmaceutical market – Attractiveness Analysis
      1. 8.6.1. By Type
      2. 8.6.2. By Application
      3. 8.6.3. By Region
  9. CHAPTER 9. Raw Material analysis
    1. 9.1. Radiopharmaceutical Key Raw Material Analysis
      1. 9.1.1. Key Raw Materials
      2. 9.1.2. Price Trend of Key Raw Materials
    2. 9.2. Key Suppliers of Raw Materials
    3. 9.3. Proportion of Manufacturing Cost Structure
      1. 9.3.1. Raw Materials
      2. 9.3.2. Labor Cost
    4. 9.4. Manufacturing Expenses Analysis of Radiopharmaceutical
  10. CHAPTER 10. Industrial Chain, Sourcing Strategy and Downstream Buyers
    1. 10.1. Radiopharmaceutical Industrial Chain Analysis
    2. 10.2. Upstream Raw Materials Sourcing
      1. 10.2.1. Risk Mitigation:
      2. 10.2.2. Supplier Relationships:
      3. 10.2.3. Business Processes:
      4. 10.2.4. Securing the Product:
    3. 10.3. Raw Materials Sources of Radiopharmaceutical Major Manufacturers in 2016
    4. 10.4. Downstream Buyers
    5. 10.5. Distributors/Traders List
  11. CHAPTER 11. Marketing Strategy Analysis, Distributors
    1. 11.1. Marketing Channel
    2. 11.2. Direct Marketing
    3. 11.3. Indirect Marketing
    4. 11.4. Marketing Channel Development Trend
    5. 11.5. Economic/Political Environmental Change
  12. CHAPTER 12. Report Conclusion
  13. CHAPTER 13. Research Approach & Methodology
    1. 13.1. Report Description
    2. 13.2. Research Scope
    3. 13.3. Research Methodology
      1. 13.3.1. Secondary Research
      2. 13.3.2. Primary Research
      3. 13.3.3. Models

      List of Figures

      FIG. 1 Global Radiopharmaceutical Market, 2016-2026(USD Billion)
      FIG. 2 Global Radiopharmaceutical MarketShare, by Type, 2019 & 2026 (USD Billion)
      FIG. 3 Global Radiopharmaceutical Market share, by Type, 2019 & 2026 (K Units)
      FIG. 4 Global DiagnosticRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      FIG. 5 Global DiagnosticRadiopharmaceutical  Market, 2016-2026 (K Units)
      FIG. 6 Global TherapeuticRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      FIG. 7 Global TherapeuticRadiopharmaceutical  Market, 2016-2026 (K Units)
      FIG. 8 Global Radiopharmaceutical MarketShare, by Application, 2019 & 2026 (USD Billion)
      FIG. 9 Global Radiopharmaceutical Market share, by Application, 2019 & 2026 (K Units)
      FIG. 10 Global NeurologyRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      FIG. 11 Global NeurologyRadiopharmaceutical  Market, 2016-2026 (K Units)
      FIG. 12 Global OncologyRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      FIG. 13 Global OncologyRadiopharmaceutical  Market, 2016-2026 (K Units)
      FIG. 14 Global ThyroidRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      FIG. 15 Global ThyroidRadiopharmaceutical  Market, 2016-2026 (K Units)
      FIG. 16 Global CardiologyRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      FIG. 17 Global CardiologyRadiopharmaceutical  Market, 2016-2026 (K Units)
      FIG. 18 Global OthersRadiopharmaceuticalMarket,2016-2026 (USD Billion)
      FIG. 19 Global OthersRadiopharmaceutical  Market, 2016-2026 (K Units)
      FIG. 20 Global Radiopharmaceutical MarketShare, by Region, 2019 & 2026
      FIG. 21 Global Radiopharmaceutical MarketShare, by Region, 2019 & 2026
      FIG. 22 Global Radiopharmaceutical production and revenue, 2016-2026 (USD Billion) (K Units)
      FIG. 23 North AmericaRadiopharmaceutical production and revenue, 2016-2026 (USD Billion) (K Units)
      FIG. 24 EuropeRadiopharmaceutical production and revenue, 2016-2026 (USD Billion) (K Units)
      FIG. 25 Asia Pacific Radiopharmaceutical production and revenue, 2016-2026 (USD Billion) (K Units)
      FIG. 26 Latin America Radiopharmaceutical production and revenue, 2016-2026 (USD Billion) (K Units)
      FIG. 27 Middle East and Africa Radiopharmaceutical production and revenue, 2016-2026 (USD Billion) (K Units)
      FIG. 28 Competitor Market Share – Revenue
      FIG. 29 Competitor Market Share – Volume
      FIG. 30 Lantheus Medical Imaging Revenue and Growth Rate
      FIG. 31 Lantheus Medical Imaging Market Share
      FIG. 32 Inc. Revenue and Growth Rate
      FIG. 33 Inc. Market Share
      FIG. 34 Cardinal Health Inc. Revenue and Growth Rate
      FIG. 35 Cardinal Health Inc. Market Share
      FIG. 36 GE Healthcare Revenue and Growth Rate
      FIG. 37 GE Healthcare Market Share
      FIG. 38 Nordion Revenue and Growth Rate
      FIG. 39 Nordion Market Share
      FIG. 40 Inc. Revenue and Growth Rate
      FIG. 41 Inc. Market Share
      FIG. 42 Eczacibasi-Monrol Nuclear Products Revenue and Growth Rate
      FIG. 43 Eczacibasi-Monrol Nuclear Products Market Share
      FIG. 44 Bracco Imaging S.p.A Revenue and Growth Rate
      FIG. 45 Bracco Imaging S.p.A Market Share
      FIG. 46 Nihon Medi-Physics Co. Revenue and Growth Rate
      FIG. 47 Nihon Medi-Physics Co. Market Share
      FIG. 48 Ltd. Revenue and Growth Rate
      FIG. 49 Ltd. Market Share
      FIG. 50 and Advanced Accelerator Applications S.A Revenue and Growth Rate
      FIG. 51 and Advanced Accelerator Applications S.A Market Share
      FIG. 52 Curium Revenue and Growth Rate
      FIG. 53 Curium Market Share
      FIG. 54 Market Dynamics
      FIG. 55 Global Radiopharmaceutical – Value Chain Analysis
      FIG. 56 Key Mandates and Regulations
      FIG. 57 Technology Roadmap and Timeline
      FIG. 58 Market Attractiveness Analysis – By Type
      FIG. 59 Market Attractiveness Analysis – By Application
      FIG. 60 Market Attractiveness Analysis – By Region
      FIG. 61 Manufacturing Cost Structure of Radiopharmaceutical
      FIG. 62 Radiopharmaceutical Industrial Chain Analysis
      FIG. 63 Market Channel
      FIG. 64 Marketing Channel Development Trend
      FIG. 65 Growth in World Gross Product, 2008-2019
      

      List of Tables

      TABLE 1 Global Radiopharmaceutical market, 2019& 2026 (USD Billion)
      TABLE 2 Global Radiopharmaceutical market, by Type, 2016-2026 (USD Billion)
      TABLE 3 Global Radiopharmaceutical market, by Type, 2016-2026 (K Units)
      TABLE 4 Global Radiopharmaceutical market, by Application, 2016-2026 (USD Billion)
      TABLE 5 Global Radiopharmaceutical market, by Application, 2016-2026 (K Units)
      TABLE 6 Global Radiopharmaceutical market, by region, 2016-2026 (USD Billion)
      TABLE 7 Global Radiopharmaceutical market, by region, 2016-2026 (K Units)
      TABLE 8 North America RadiopharmaceuticalProduction, Consumption, Export, Import, 2016-2019
      TABLE 9 Europe RadiopharmaceuticalProduction, Consumption, Export, Import, 2016-2019
      TABLE 10 Asia Pacific RadiopharmaceuticalProduction, Consumption, Export, Import, 2016-2019
      TABLE 11 Latin America RadiopharmaceuticalProduction, Consumption, Export, Import, 2016-2019
      TABLE 12 Middle East & Africa RadiopharmaceuticalProduction, Consumption, Export, Import, 2016-2019
      TABLE 13 Global Radiopharmaceutical Market - Company Revenue Analysis 2016-2019 (USD Billion)
      TABLE 14 Global Radiopharmaceutical Market - Company Revenue Share Analysis 2016-2019(%)
      TABLE 15 Global Radiopharmaceutical Market - Company Volume Analysis 2016-2019 (K Units)
      TABLE 16 Global Radiopharmaceutical Market - Company Volume Share Analysis 2016-2019(%)
      TABLE 17 Acquisitions and Mergers
      TABLE 18 New Product/Service Launch
      TABLE 19 Research & Development Activities
      TABLE 20 Market Drivers
      TABLE 21 Market Restraints
      TABLE 22 Market Opportunities
      TABLE 23 Production Base and Market Concentration Rate of Raw Material
      TABLE 24 Key Suppliers of Raw Materials
      TABLE 25 Raw Materials Sources of Radiopharmaceutical Major Manufacturers in 2016
      TABLE 26 Major Buyers of Radiopharmaceutical
      TABLE 27 Distributors/Traders of Radiopharmaceutical by Region
      

logoKey Insights from Primary Research

  • The market was valued at USD 3.88 billion, in 2019 and is expected to be valued over USD 5.87 billion.
  • According to the primary CXO’s of the global radiopharmaceutical market, the market is estimated to witness a substantial growth of nearly 6.1% over the forecast period.
  • On the basis of the product segment, diagnostic dominated the global radiopharmaceutical market in 2019. In terms of revenue, it accounted for more than a 90% share of the total market in 2019.
  • Application-wise, the cardiology segment was the largest of the global radiopharmaceutical market in 2019. It was accounted more than 30% of total market share in 2019.
  • By geography, the North America region headed the market with a share of above 35%, in 2019.

logoKey Recommendations from Analysts

  • According to the industry expertise, the increasing incidences of neurological, cardiac, and cancer diseases across the globe is expected to boom the demand for radiopharmaceuticals over the future years.
  • Our analysts recommend that the Asia Pacific region is predicted to witness a significant growth attributed to the growing demand for radiopharmaceutical from China and India.
  • According to our analyst, the surging demand for therapeutic isotopes due to the raise in the relevances of these isotopes in oncology and these isotopes have nominal side effects.
  • PET has high demand in the radiopharmaceutical industry due to the it offers high perforemance than the SPECT and it is less expensive than SPECT.
  • According to our analysis, the therapeutic segment is expected to grow with a highest CAGR over the forthcoming period.

logoMarket Share Analysis by Region

Industry Major Market Players

  • Lantheus Medical Imaging Inc.
  • Cardinal Health Inc.
  • GE Healthcare
  • Nordion Inc.
  • Eczacibasi-Monrol Nuclear Products
  • Bracco Imaging S.p.A
  • Nihon Medi-Physics Co. Ltd.
  • Advanced Accelerator Applications S.A
  • Curium

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Radiopharmaceutical Market.
According to Facts and Factors research report, the global Radiopharmaceutical Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Radiopharmaceutical Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Radiopharmaceutical Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Radiopharmaceutical Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Corporate Wellness Market

[205+ Pages Report] According to a Facts and Factors market research report, the globalcorporate wellness solutions market is projected to reach USD 100 Billion by 2026 from USD 61.3 Billion in 2020, at a CAGR of 8.5% during the forecast period. Global Corporate Wellness Market: Overview Corpo...

Published Date : 27-Sep-2021 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample
report img

Medical Polymers Market

[203+ Pages Report] According to a survey released by Facts and Factors, the globalmedical polymers market was valued at USD 16,500 Million in 2020 and is predicted to reach USD 28,290 Million by the end of 2026, rising at a CAGR of nearly 9.40% between 2021 and 2026. Global Medical Polymers Mar...

Published Date : 08-Sep-2021 | | Category : | Pages : 203 | Format : Read more

Inquiry for Buying Request Sample